翻訳と辞書 |
Ixekizumab
Ixekizumab is a humanized monoclonal antibody for the treatment of autoimmune diseases.〔(【引用サイトリンク】publisher=American Medical Association )〕 More specifically, it is being tested for the use in psoriasis. A Phase II clinical trial including patients with moderate to severe psoriasis has been completed, and a Phase III open-label trial is under way . Ixekizumab was developed by Eli Lilly and Co. == Mechanism of action == Ixekizumab binds to interleukin 17 and blocks its action. This mechanism is similar to that of another anti-psoriasis antibody, brodalumab, which however binds to the interleukin-17 receptor.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ixekizumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|